Inorganic Chemistry
Article
191.4, 140.6, 129.1, 127.8, 122.8, 115.5, 109.0, 29.3, 24.4. Elem anal.
Calcd for C23H23NO4: C, 73.19; H, 6.14; N, 3.71. Found: C, 73.17; H,
6.09; N, 3.69. ESI-MS anal. Calcd for [C23H23NO4 + Na]+: m/z
400.1519. Found: m/z 400.1521.
H), 7.86−7.80 (m, 6H, Cz−H and Cz−Ar−H), 7.75−7.73 (d, J = 8.5
Hz, 2H, Cz−H), 7.43−7.40 (d, J = 8.2 Hz, 4H, Ar−H), 7.33−7.24 (m,
5H, Ar−H), 5.74 (s, 2H, −CH2), 2.27 (s, 12H, −CH3). 13C NMR
(100 MHz, DMSO-d6, 25 °C, Si(CH3)4, ppm): δ 141.0, 140.6, 138.9,
138.2, 132.6, 131.9, 129.6, 129.1, 127.8, 127.2, 125.4, 123.7, 119.2,
117.1, 110.5, 46.3, 12.0. Elem anal. Calcd for C41H35N5·H2O: C, 79.97;
H, 6.06; N, 11.37. Found: C, 79.94; H, 6.08; N, 11.36. ESI-MS anal.
Calcd for [C41H35N5 + H]+: m/z 598.2965. Found: m/z 598.2922.
[(phen)8Pd8L14](NO3)8 (1·8NO3−), [(phen)8Pd8L14](PF6)8
3,3′-(9-Benzyl-9H-carbazole-3,6-diyl)bis(4-hydroxypent-3-en-2-
one) (b). The above general acetylacetone preparation procedure was
followed with 9-benzylcarbazole-3,6-dicarbaldehyde (2.63 g, 8.4
mmol) to give b as a light-yellow powder. The product was
1
vacuum-dried (762 mg, 20%). H NMR (400 MHz, CDCl3, 25 °C,
(1·8PF6−), and [(phen)8Pd8L1 ](BF4)8 (1·8BF4−)
Si(CH3)4, ppm): δ 16.75 (s, 2H, −OH), 7.92−7.91 (d, J = 1.4 Hz, 2H,
Cz−H), 7.45−7.42 (d, J = 8.3 Hz, 2H, Cz−H), 7.36−7.31 (m, 3H,
Ar−H), 7.28−7.27 (d, J = 1.7, 2H, Cz−H), 7.25 (m, 2H, Ar−H), 5.57
(s, 2H, −CH2), 1.96 (s, 12H, −CH3). 13C NMR (100 MHz, CDCl3,
25 °C, Si(CH3)4, ppm): δ 191.3, 140.8, 139.6, 138.4, 128.6, 128.1,
127.6, 126.4, 125.7, 118.3, 109.4, 46.9, 24.2. Elem anal. Calcd for
C29H27NO4: C, 76.80; H, 6.00; N, 3.09. Found: C, 76.82; H, 6.09; N,
3.03. ESI-MS anal. Calcd for [C29H27NO4 + Na]+: m/z: 476.1832.
Found: m/z 476.1803.
3,3′-[(9-Benzyl-9H-carbazole-3,6-diyl)bis(4,1-phenylene)]bis(4-
hydroxypent-3-en-2-one) (c). The above general acetylacetone
preparation procedure was followed with 4,4′-(9-benzylcarbazole-3,6-
diyl)dibenzaldehyde (4.0 g, 8.4 mmol) to give c as a light-yellow
powder. The product was vacuum-dried (1.02 g, 20%). 1H NMR (400
MHz, CDCl3, 25 °C, Si(CH3)4, ppm): δ 16.74 (s, 2H, −OH), 8.47−
8.45 (s, 2H, Cz−H), 7.77−7.75 (d, J = 8.3 Hz, 4H, Cz−Ar−H), 7.77−
7.75 (covered, 2H, Cz−H), 7.50−7.48 (d, J = 8.2 Hz, 2H, Cz−H),
7.32−7.21 (m, 9H, Cz−Ar−H and Ar−H), 5.61 (s, 2H, −CH2), 1.99
(s, 12H, −CH3). 13C NMR (100 MHz, CDCl3, 25 °C, Si(CH3)4,
ppm): δ 191.1, 141.0, 140.8, 136.9, 135.1, 132.3, 131.6, 128.9, 127.7,
127.6, 126.5, 125.5, 123.8, 118.9, 114.9, 109.5, 46.9, 24.3. Elem anal.
Calcd for C41H35NO4: C, 81.30; H, 5.82; N, 2.31. Found: C, 81.27; H,
5.85; N, 2.32. ESI-MS anal. Calcd for [C41H35NO4 + Na]+: m/z
628.2488. Found: m/z 628.2403.
9-Methyl-3,6-bis[3-(trifluoromethyl)-1H-pyrazol-5-yl]-9H-carba-
zole (H2L1). The above general pyrazole preparation procedure was
followed with 1,1′-(9-methylcarbazole-3,6-diyl)bis(4,4,4-trifluorobu-
tane-1,3-dione) (755 mg, 1.68 mmol), and a white solid of H2L1
was obtained (717 mg, 95%). 1H NMR (400 MHz, DMSO-d6, 25 °C,
Si(CH3)4, ppm): δ 14.06 (s, 2H, −NH), 8.66 (s, 2H, Cz−H), 7.99−
7.97 (d, J = 8.8 Hz, 2H, Cz−H), 7.79−7.77 (d, J = 8.6 Hz, 2H, Cz−
H), 7.18 (s, 2H, −CH), 3.97 (s, 3H, N−CH3).
3,6-Bis(3,5-dimethyl-1H-pyrazol-4-yl)-9-methyl-9H-carbazole
(H2L2). The above general pyrazole preparation procedure was
followed with a (634 mg, 1.68 mmol), and a white solid of H2L2
was obtained (590 mg, 95%). 1H NMR (400 MHz, DMSO-d6, 25 °C,
Si(CH3)4, ppm): δ 12.23 (s, 2H, −NH), 8.08 (d, J = 1.3 Hz, 2H, Cz-
H), 7.62−7.60 (d, J = 8.3 Hz, 2H, Cz−H), 7.38−7.35 (d, J1 = 8.4 Hz,
J2 = 3.2 Hz, 2H, Cz−H), 3.91 (s, 3H, N−CH3), 2.23 (s, 12H, −CH3).
13C NMR (100 MHz, DMSO-d6, 25 °C, Si(CH3)4, ppm): δ 139.9,
4
Self-Assembly of MetallomacrocyclesGeneral Procedures
[(phen)2Pd2(NO3)2](NO3)2 (18.3 mg, 0.02 mmol) was added to a
suspension of H2L1 (10 mg, 0.02 mmol) in a H2O (1 mL) and acetone
(0.5 mL) solution. The mixture was stirred for 2 h at room
temperature and was then heated at 60 °C for another 24 h to react
fully. After that, the resulting solution was filtered, and the clear yellow
filtrate was evaporated to dryness to give a yellow solid of 1·8NO3−.
Yield: 19 mg (67%). The PF6− salt of 1 (1·8PF6−) was prepared by
anion exchange of 1·8NO3− with a 10-fold excess of KPF6 in a
methanol solution in quantitative yield. 1H NMR (400 MHz, CD3CN,
25 °C, Si(CH3)4, ppm): δ 9.11 (s, 4H), 8.84−8.82 (d, J = 7.9 Hz, 4H),
8.79−8.77 (d, J = 8.0 Hz, 4H), 8.68−8.66 (d, J = 8.2 Hz, 4H), 8.65−
8.64 (d, J = 5.4 Hz, 4H), 8.57−8.55 (d, J = 5.0 Hz, 4H), 8.40−8.38 (d,
J = 8.2 Hz, 4H), 8.24−8.22 (d, J = 5.3 Hz, 4H), 8.15−8.12 (dd, J1 = 8.3
Hz, J2 = 1.5 Hz, 4H), 8.14 (s, 8H), 7.93−7.90 (d, J = 8.8 Hz, 4H),
7.91−7.88 (dd, J1 = 8.2 Hz, J2 = 5.5 Hz, 4H), 7.85−7.83 (d, J = 5.7 Hz,
4H), 7.83−7.81 (d, J = 7.9 Hz, 4H), 7.82−7.79 (d, J = 8.7 Hz, 4H),
7.76 (s, 4H), 7.76−7.72 (dd, J1 = 8.2 Hz, J2 = 5.5 Hz, 4H), 7.69−7.68
(d, J = 5.2 Hz, 4H), 7.63−7.61 (d, J = 8.5 Hz, 4H), 7.35−7.32 (dd, J1 =
8.3 Hz, J2 = 5.5 Hz, 4H), 7.25 (s, 4H), 6.95 (s, 4H), 6.67−6.65 (d, J =
8.5 Hz, 4H), 3.68 (s, 12H). ESI-MS (acetonitrile): m/z 1602.33
([1·5PF6−]3+). Elem anal. Calcd for C180H108N36Pd8P8F72·2H2O: C,
40.96; H, 2.14; N, 9.55. Found: C, 40.86; H, 2.34; N, 9.43. The BF4−
salt of 1 (1·8BF4−) was also obtained as yellow microcrystals in
quantitative yield. X-ray-quality crystals were grown by the slow vapor
diffusion of diethyl ether into a solution of 1·8BF4− in acetonitrile at
room temperature.[(dmbpy)4Pd4L1 ](NO3)4 (2·4NO3−) and
2
[(dmbpy)4Pd4L1 ] (BF4)4 (2·4BF4−)
2
The same procedure as that employed for 1·8NO3− was used to make
2·4NO3−, except that [(dmbpy)2Pd2(NO3)2](NO3)2 (18.5 mg, 0.02
mmol) was used as the starting material. Yield: 21.4 mg (75%). The
BF4− salt of 2 (2·4BF4−) was prepared by anion exchange of 2·4NO3−
with a 10-fold excess of KBF4 in a methanol solution in quantitative
yield. 1H NMR (400 MHz, CD3CN, 25 °C, Si(CH3)4, ppm): δ 8.92 (s,
2H), 8.25 (s, 2H), 8.20 (s, 2H), 8.15−8.14 (d, J = 5.9 Hz, 2H), 8.12−
8.10 (d, J = 5.9 Hz, 2H), 8.03−8.00 (dd, J1 = 8.5 Hz, J2 = 1.7 Hz, 2H),
7.90 (s, 2H), 7.72 (s, 2H), 7.67 (s, 2H), 7.60−7.58 (d, J = 5.9 Hz, 2H),
7.57 (s, 2H), 7.54−7.52 (d, J = 8.5 Hz, 2H), 7.46−7.44 (d, J = 6.2 Hz,
2H), 7.35−7.33 (t, J = 4.7 Hz, 4H), 7.16−7.14 (d, J = 5.9 Hz, 2H),
6.90 (s, 2H), 6.84 (s, 2H), 6.82−6.80 (d, J = 8.6 Hz, 2H), 6.79−6.77
(d, J = 6.5 Hz, 2H), 3.76 (s, 6H), 2.59 (s, 8H), 2.56 (s, 8H), 2.42 (s,
8H). ESI-MS (acetonitrile): m/z 1115.61 ([2·2BF4−]2+) and 713.74
([2·BF4−]3+). Elem anal. Calcd for C90H70N18Pd4B4F28·H2O: C, 44.62;
H, 3.00; N, 10.41. Found: C, 44.46; H, 2.84; N, 10.33.
[(phen)4Pd4L2 ](NO3)4 (3·4NO3−) and [(phen)4Pd4L2 ](BF4)4
127.6, 125.0, 122.8, 121.1, 118.4, 109.4, 56.5, 29.5, 19.0, 11.9. Elem
anal. Calcd for C23H23N5·H2O: C, 71.29; H, 6.50; N, 18.07. Found: C,
71.37; H, 6.59; N, 18.01. ESI-MS anal. Calcd for [C23H23N5 + H]+: m/
z 370.2026. Found: m/z 370.2037.
9-Benzyl-3,6-bis(3,5-dimethyl-1H-pyrazol-4-yl)-9H-carbazole
(H2L3). The above general pyrazole preparation procedure was
followed with b (762 mg, 1.68 mmol), and a white solid of H2L3
was obtained (711 mg, 95%). 1H NMR (400 MHz, DMSO-d6, 25 °C,
Si(CH3)4, ppm): δ 12.23 (s, 2H, −NH), 8.11 (d, J = 1.2 Hz, 2H, Cz−
H), 7.66−7.63 (d, J = 8.5 Hz, 2H, Cz−H), 7.24−7.35 (m, 7H, Cz−H
and Ar−H), 5.67 (s, 2H, N−CH2), 2.09 (s, 12H, −CH3). 13C NMR
(100 MHz, DMSO-d6, 25 °C, Si(CH3)4, ppm): δ 140.8, 139.4, 138.4,
129.1, 127.8, 127.6, 127.4, 125.3, 123.0, 121.2, 118.2, 109.8, 46.3, 11.9.
Elem anal. Calcd for C29H27N5·2H2O: C, 72.33; H, 6.49; N, 14.54.
Found: C, 72.31; H, 6.49; N, 14.51. ESI-MS anal. Calcd for [C29H27N5
+ H]+: m/z: 446.2339. Found: m/z 446.2315.
2
2
(3·4BF4−)
The same procedure as that employed for 1·8NO3− was used to make
3·4NO3−, except that [(phen)2Pd2(NO3)2](NO3)2 (33.6 mg, 0.04
mmol) and H2L2 (15 mg, 0.04 mmol) were used as starting materials.
Yield: 37.7 mg (80%). The BF4− salt of 3 (3·4BF4−) was prepared by
exchange with a 10-fold excess of KBF4 in a methanol solution in
quantitative yield. Pure 3·4BF4−, as a microcrystalline light-yellow
solid, was obtained by the vapor diffusion of diethyl ether into a
solution of 3·4BF4− in acetonitrile at room temperature. Yield: 20 mg
(53%). 1H NMR (400 MHz, CD3CN, 25 °C, Si(CH3)4, ppm): δ
9.08−9.06 (d, J = 8.2 Hz, 8H, phen−H), 8.70−8.69 (d, J = 4.9 Hz, 8H,
phen−H), 8.35 (s, 8H, phen−H), 8.19−8.15 (dd, J1 = 8.2 and 5.3 Hz,
8H, phen−H), 8.15 (s, 4H, Cz-H), 7.75−7.73 (d, J = 8.7 Hz, 4H, Cz−
H), 7.68−7.65 (d, J = 8.6 Hz, 4H, Cz−H), 3.98 (s, 6H, N−CH3), 2.60
(s, 24H, L2−CH3). ESI-MS (acetonitrile): m/z 1027.63 ([3·2BF4−]2+).
9-Benzyl-3,6-bis[4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]-9H-car-
bazole (H2L4). The above general pyrazole preparation procedure was
followed with c (1.02 g, 1.68 mmol), and a white solid of H2L4 was
1
obtained (954 mg, 95%). H NMR (400 MHz, DMSO-d6, 25 °C,
Si(CH3)4, ppm): δ 12.35 (s, 2H, −NH), 8.80 (d, J = 0.8 Hz, 2H, Cz−
2451
dx.doi.org/10.1021/ic202407b | Inorg. Chem. 2012, 51, 2443−2453